Corgenix Medical Corp. (CONX) posted third-quarter sales of $2.1 million for the three months ended Sept. 30, up 2.2 percent compared with $2 million during the same period last year. The Denver-based diagnostics maker also cut its net loss down to the bone, at $7,000, compared with a net loss of $341,000 during Q3 2008:
MassDevice Earnings Roundup
AdvanSource Biomaterials Corp. (ASB) took a step backwards during the second quarter, when sales slid nearly 50 percent, but still managed to eke out a net profit for the three months ended Sept. 30.
The Wilmington, Mass.-based firm, which makes polymers used for medical devices, posted sales of $518,000 during the second quarter of fiscal 2010, down 47.6 percent compared with $989,000 during the same period last year.
Cardiogenesis Corp. (CGCP) posted third-quarter sales of $2.1 million for the three months ended Sept. 30, down 18.5 percent compared with $2.6 million during the same period last year. The Irvine, Calif.-based laser angina treatment maker reported Q3 net losses of $739,000, compared with net losses of $308,000 during Q3 2008:
Cardiogenesis Reports Third Quarter 2009 Results
According to CEO Richard Packer, Zoll Medical Corp. “took it on the chin” during the fourth quarter and much of 2009, on the ropes as slumping spending on big-ticket equipment hit its top- and bottom-line results.
The Chelmsford, Mass.-based resuscitation device maker posted sales of $385.2 million during fiscal 2009, down 3.2 percent compared with $398 million during the prior year. Annual net income slumped 59.2 percent to $9.6 million, compared with $23.4 million during fiscal 2008.
Cardium Therapeutics posted third-quarter sales of $236,000 for the three months ended Sept. 30, compared with no sales during the same period last year, and swung from a $6.2 million net loss during Q3 2008 to net income of $4.9 million:
Cardium Reports on Third Quarter 2009 Financial Results and Recent Developments
Three months ago PLC Systems Inc. hit a double, halving its second-quarter net losses and signing a distribution deal for Bangladesh and Pakistan.
Jack Cumming’s tenure in the corner office at Hologic Inc. is over, as the 63-year-old exec steps aside to make way for Rob Cascella, the company’s current president and COO.
Hologic said Cumming, who has held his post since 2001, will retain his post as chairman of the board of directors. In his eight years at the helm of the Bedford, Mass.-based women’s healthcare products firm, Hologic grew from $75 million in annual sales to more than $1.6 billion.
Allied Healthcare Products Inc. posted first-quarter sales of $11.3 million for the three months ended Sept. 30, down 21.6 percent compared with $14.4 million during the first quarter of fiscal 2009. The company swung to a net loss of $745,000 for Q1 2010, compared with net income of $208,400 during Q1 2009:
Recession Continues to Depress Sales at Allied Healthcare Products
Biomet Inc. posted (PDF) first-quarter sales of $630 million for the three months ended August 31, up 3.8 percent compared with $607 million during the same period during fiscal 2009. Net losses narrowed 62 percent to $23 million during the first quarter of fiscal 2010, compared with net losses of $60 million during Q1 2009: